ENTR'UP Entr'up develops and markets a software tool for managing...
MASTERBOX MASTERBOX is a box that makes it possible to offer one or more products from the best French craftsmen: choice of gift, visibility to the...
LOUTSA Establishment and development in France and abroad of "coffee factories" (shops) which offer the sale of coffees in bags or bulk, machines and accessories with a tasting...
LINKYVET Linkyvet, telemedicine solution (teleconsultation by visio and/or chat) for...
LACLAREE Laclarée is a start-up company developing a novel eyewear solution for presbyopia...
« Older Entries
Theranexus presents an update on the progress of its main programs and announces its cash position as of 31 December 2020. Implemantation of a new equity line.
Amolyt Pharma Receives Orphan Drug Designation for AZP-3601 for the Potential Treatment of Hypoparathyroidism
Theranexus, Lyon Neuroscience Research Center and CERMEP announce the creation and funding of new joint public/ private laboratory “NeuroImaging for Drug Discovery” (NI2D)
Amolyt Pharma announces research collaboration with PeptiDream
The Food and Drug Administration (FDA) issues a favorable opinion on the preclinical development plan submitted by Theranexus and BBDF